Literature DB >> 19527419

Validation of a client-based clinical metrology instrument for the evaluation of canine elbow osteoarthritis.

C A Hercock1, G Pinchbeck, A Giejda, P D Clegg, J F Innes.   

Abstract

OBJECTIVE: To validate a disease-specific client-based clinical metrology instrument (questionnaire) for dogs with chronic osteoarthritis of the elbow joint.
MATERIALS AND METHODS: This was a prospective cohort study involving 26 dogs with chronic osteoarthritis of the elbow with 24 associated clients. Validity (face and criterion), reliability and responsiveness of the metrology instrument (named "Liverpool Osteoarthritis in Dogs [elbow]") were tested in a sequence of studies. Face validity involved use of international peer review. Reliability was assessed using a test-retest scenario with a two week interval; peak vertical force as measured by a force platform was used as an external standard measure. Responsiveness was tested with a two week, single-blinded placebo-controlled intervention using a licensed non-steroidal anti-inflammatory drug.
RESULTS: The reliability of Liverpool Osteoarthritis in Dogs (elbow) in the test-retest scenario was good; intraclass correlation coefficient is 0.89, 95 per cent confidence interval 0.75 to 0.95, compared with intraclass correlation coefficient 0.92, 95 per cent confidence interval 0.74 to 0.98, for peak vertical force. Responsiveness testing indicated that the "net" effect size (allowing for placebo effect) for Liverpool Osteoarthritis in Dogs (elbow) was 0.13 compared with (-)0.18 for the force platform. Criterion validity for Liverpool Osteoarthritis in Dogs (elbow) against peak vertical force was poor; Spearman's rank correlation is -0.24 (P=0.30). CLINICAL SIGNIFICANCE: Liverpool Osteoarthritis in Dogs (elbow) was considered reliable with satisfactory responsiveness. The poor criterion validity suggests a mismatch between force platform peak vertical force and client perceptions of lameness. This instrument requires further validation in larger studies with alternative client groups and alternative therapeutic interventions, but this initial validation suggests that Liverpool Osteoarthritis in Dogs (elbow) is worthy of continued investigation.

Entities:  

Mesh:

Year:  2009        PMID: 19527419     DOI: 10.1111/j.1748-5827.2009.00765.x

Source DB:  PubMed          Journal:  J Small Anim Pract        ISSN: 0022-4510            Impact factor:   1.522


  23 in total

1.  Contribution of Habitual Activity to Cruciate Ligament Rupture in Labrador Retrievers.

Authors:  Hannah M Terhaar; Peter Muir; Lauren A Baker; Emily E Binversie; Jacqueline Chi; Susannah J Sample
Journal:  Vet Comp Orthop Traumatol       Date:  2020-01-08       Impact factor: 1.358

2.  A Pilot, Open-Label Study to Evaluate the Efficacy of Intra-Articular Administration of a Caninized TNF Receptor Fc Fusion Protein as a Treatment for Osteoarthritis-Associated Joint Pain.

Authors:  Aoi Nakanishi; B Duncan X Lascelles; Julie Allen; Beth Case; David Gearing; Masataka Enomoto
Journal:  Front Vet Sci       Date:  2022-06-02

Review 3.  The challenges of assessing osteoarthritis and postoperative pain in dogs.

Authors:  Michele Sharkey
Journal:  AAPS J       Date:  2013-03-02       Impact factor: 4.009

4.  Contralateral cruciate survival in dogs with unilateral non-contact cranial cruciate ligament rupture.

Authors:  Peter Muir; Zeev Schwartz; Sarah Malek; Abigail Kreines; Sady Y Cabrera; Nicole J Buote; Jason A Bleedorn; Susan L Schaefer; Gerianne Holzman; Zhengling Hao
Journal:  PLoS One       Date:  2011-10-05       Impact factor: 3.240

5.  Biceps femoris muscle transposition for treatment of cranial cruciate ligament rupture in small breed dogs.

Authors:  Roberto Tamburro; Stefania Pinna; Anna Maria Tribuiani; Alessandra Panacea; Fabio Carli; Antonio Venturini
Journal:  J Vet Sci       Date:  2012-03       Impact factor: 1.672

6.  Comparative efficacy and safety of mavacoxib and carprofen in the treatment of canine osteoarthritis.

Authors:  M Payne-Johnson; C Becskei; Y Chaudhry; M R Stegemann
Journal:  Vet Rec       Date:  2014-11-27       Impact factor: 2.695

7.  A canine-specific anti-nerve growth factor antibody alleviates pain and improves mobility and function in dogs with degenerative joint disease-associated pain.

Authors:  B Duncan X Lascelles; David Knazovicky; Beth Case; Mila Freire; John F Innes; Alexander C Drew; David P Gearing
Journal:  BMC Vet Res       Date:  2015-04-30       Impact factor: 2.741

8.  Global positioning system derived performance measures are responsive indicators of physical activity, disease and the success of clinical treatments in domestic dogs.

Authors:  Elizabeth A Bruno; James W Guthrie; Stephen A Ellwood; Richard J Mellanby; Dylan N Clements
Journal:  PLoS One       Date:  2015-02-18       Impact factor: 3.240

9.  Effect of analgesic therapy on clinical outcome measures in a randomized controlled trial using client-owned dogs with hip osteoarthritis.

Authors:  Sarah Malek; Susannah J Sample; Zeev Schwartz; Brett Nemke; Peer B Jacobson; Elizabeth M Cozzi; Susan L Schaefer; Jason A Bleedorn; Gerianne Holzman; Peter Muir
Journal:  BMC Vet Res       Date:  2012-10-04       Impact factor: 2.741

10.  Evaluation of construct and criterion validity for the 'Liverpool Osteoarthritis in Dogs' (LOAD) clinical metrology instrument and comparison to two other instruments.

Authors:  Myles Benjamin Walton; Emily Cowderoy; Duncan Lascelles; John F Innes
Journal:  PLoS One       Date:  2013-03-07       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.